Years after her initial breast cancer diagnosis, 81-year-old Vici Robinson found out her cancer had recurred. Now, with the help of Dana-Farber’s Program for Older Adults with Breast Cancer and her care team, Vici is living life to the fullest. ms.spr.ly/6013lvfpd

Now through August 25, you can participate in @99Restaurants’ annual fundraiser, which directly benefits Dana-Farber patients like Olivia, who is one year into her two-year treatment plan for B-cell acute lymphoblastic leukemia in Dana-Farber's Jimmy Fund Clinic. “Olivia has

Join the Dana-Farber Adult #Survivorship team in our Sexual Health and Prostate Cancer Group via Zoom📅 Tues, September 17th, 3-4:15p ET. Open to all Dana-Farber patients with prostate cancer. Contact [email protected] for details. #ProstateCancer #SexualHealth

How do you know if you're at higher risk for skin cancer? Family history and increased sun and UV exposure raise skin cancer risk. Elizabeth Buchbinder, MD, breaks down the risk factors for skin cancer. Learn more: ms.spr.ly/6016lvf8A

Today, we celebrate the many shining examples of work and progress conceived, managed, and led by women that is happening in labs, clinics, offices, and meeting rooms at Dana-Farber. This critical work is only possible through our collective efforts to nurture and sustain a

Shirley and Mike Joseph share their story of Shirley's #InflammatoryBreastCancer diagnosis and treatment Dana-Farber's specialized Inflammatory Breast Cancer Program. #IBC Dana-Farber IBC Program Letícia Varella 👉Full story here: blog.dana-farber.org/insight/2024/0…

“If we can identify neoantigens specific to a patient’s tumor, we can make a personalized vaccine to target those tumor-specific antigens,” says David Braun, MD, PhD, a Dana-Farber oncologist leading a trial of a neoantigen-based vaccine for kidney cancer. ms.spr.ly/6016lv4Oj

Research in NEJM published by Dana-Farber's Toni Choueiri, MD supports belzutifan as a new treatment option in patients with advanced #kidneycancer. Read more from a woman who saw her tumors shrink after starting the treatment. ➡️ ms.spr.ly/6015l4MeW

Diagnosed with diffuse large B-cell lymphoma, Patricia Smith underwent a few different treatments, including a stem cell transplant. Dana-Farber’s Adult Survivorship Program has been a pillar of support for Patricia. Learn more: ms.spr.ly/6011lvAp3

A discover by Dana-Farber researchers in the Polyak Lab opens the door to potential new treatments targeting #KDM6A protein to prevent #BrainMetastasis in patients with #TrippleNegativeBreastCancer. Learn more here⬇️ blog.dana-farber.org/insight/2024/0…

Researchers at Dana-Farber have uncovered a key mechanism driving breast cancer's spread to the brain. This breakthrough opens the door to potential new treatments targeting the KDM6A protein to prevent brain metastasis. ms.spr.ly/6013lvCyV

Congratulations to our vice president for inpatient and ancillary services, Neha Gaur for being selected as one of @bosbizjournal's 40 under 40 honorees! #BBJ4040

“Dana-Farber has given me the chance to watch my son grow up, to bring a beautiful baby girl into my family, to travel again, and to live with a little more hope. The words ‘thank you’ don’t feel like enough for giving me my life back. That’s why I got involved with the Jimmy

Laurie H. Glimcher, MD, Dana-Farber’s transformative President and CEO, announced today that she will step down on October 1, 2024, and will assume the title of President Emerita. Benjamin Levine Ebert, MD, PhD, chair of Department of Medical Oncology and a world-renowned

Facing a cancer diagnosis can be overwhelming. Dana-Farber's Breast Oncology Program has a dedicated patient navigator who helps lower barriers patients face when trying to access breast cancer care. Learn more: blog.dana-farber.org/insight/2024/0…

New research reveals a potential targeted therapy for small cell #lung cancer, focusing on the SWI/SNF complex. This could offer new hope for POU2F3-positive patients with limited treatment options. Learn more: blog.dana-farber.org/insight/2024/0…

A promising combination of checkpoint inhibitors is showing effectiveness in treating chemotherapy-resistant metastatic #colorectalcancer. This development could redefine treatment options for patients. Learn more: blog.dana-farber.org/insight/2024/0…

Thank you TIME for highlighting our work in Kidney Cancer at Dana-Farber and Dana-Farber Lank Center for Genitourinary Oncology time.com/7018184/kidney…

Featured in TIME, Dana-Farber's Toni Choueiri, MD, discusses research in targeted therapies and vaccines in #kidneycancer. Toni Choueiri, MD Dana-Farber Lank Center for Genitourinary Oncology Dana-Farber Read more here: ms.spr.ly/6019m13tU

RESCHEDULED! Join the Dana-Farber Adult Survivorship team in our Sexual Health and Prostate Cancer Group via Zoom📅Thurs, September 19th, 3-4:15p ET. Open to all Dana-Farber patients with prostate cancer. Contact [email protected] for details. #ProstateCancer